201 related articles for article (PubMed ID: 32799026)
1. Association between provincial income levels and drug prices in China over the period 2010-2017.
Shi W; Wouters OJ; Liu G; Mossialos E; Yang X
Soc Sci Med; 2020 Oct; 263():113247. PubMed ID: 32799026
[TBL] [Abstract][Full Text] [Related]
2. The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period.
Wouters OJ; Sandberg DM; Pillay A; Kanavos PG
Soc Sci Med; 2019 Jan; 220():362-370. PubMed ID: 30513486
[TBL] [Abstract][Full Text] [Related]
3. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
4. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
[TBL] [Abstract][Full Text] [Related]
5. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
[TBL] [Abstract][Full Text] [Related]
6. Will the Volume-Based Procurement Policy Promote Pharmaceutical Firms' R&D Investment in China? An Event Study Approach.
Hu Y; Chen S; Qiu F; Chen P; Chen S
Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831803
[TBL] [Abstract][Full Text] [Related]
7. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
Rong X; Yin J; Duan S; Sun Q; Babar ZU
BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
[TBL] [Abstract][Full Text] [Related]
8. A review of promoting access to medicines in China - problems and recommendations.
Sun J; Hu CJ; Stuntz M; Hogerzeil H; Liu Y
BMC Health Serv Res; 2018 Feb; 18(1):125. PubMed ID: 29458428
[TBL] [Abstract][Full Text] [Related]
9. Price comparison of high-cost originator medicines in European countries.
Vogler S; Zimmermann N; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
[TBL] [Abstract][Full Text] [Related]
10. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
11. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
12. Time trends and regional variations in prices of anticancer medicines in China.
Zhang J; Hu S; Liu X; Liu X; Zhang J; Yang C; Fang Y
Front Pharmacol; 2024; 15():1397784. PubMed ID: 38813105
[TBL] [Abstract][Full Text] [Related]
13. The impact of the reference pricing policy in China on drug procurement and cost.
Jiang B; Zhou RJ; Feng XL
Health Policy Plan; 2022 Jan; 37(1):73-99. PubMed ID: 34379765
[TBL] [Abstract][Full Text] [Related]
14. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
Yang H; Dib HH; Zhu M; Qi G; Zhang X
Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?
Srivastava D; McGuire A
BMC Public Health; 2014 Jul; 14():767. PubMed ID: 25073407
[TBL] [Abstract][Full Text] [Related]
16. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings.
Russo G; McPake B
Health Policy Plan; 2010 Jan; 25(1):70-84. PubMed ID: 19843636
[TBL] [Abstract][Full Text] [Related]
17. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
18. Value-based differential pricing: efficient prices for drugs in a global context.
Danzon P; Towse A; Mestre-Ferrandiz J
Health Econ; 2015 Mar; 24(3):294-301. PubMed ID: 24327269
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia's Social Health Insurance System.
Anggriani Y; Ramadaniati HU; Sarnianto P; Pontoan J; Suryawati S
Value Health Reg Issues; 2020 May; 21():1-8. PubMed ID: 31634791
[TBL] [Abstract][Full Text] [Related]
20. Reducing Reimbursement Drug Price Risk to Enhance R&D Incentives without Raising Drug Prices/Expenditures: Implications of Simulations Based on Questionnaire Survey of Pharmaceutical Companies in Japan.
Nakamura H; Wakutsu N
Health Policy; 2020 Jul; 124(7):714-720. PubMed ID: 32475740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
